Holen Sie sich die Stockscreener-App
1.295
1.97%
0.025
Schlusskurs vom Vortag:
$1.27
Offen:
$1.27
24-Stunden-Volumen:
1.65M
Relative Volume:
0.96
Marktkapitalisierung:
$496.09M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.3632
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
+1.17%
1M Leistung:
-9.44%
6M Leistung:
+1.17%
1J Leistung:
-26.42%
1-Tages-Spanne:
$1.24
$1.3078
1-Wochen-Bereich:
$1.235
$1.34
52-Wochen-Spanne:
$0.92
$2.14
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.29 | 488.40M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
127.19 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.69 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.17 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Standard BioTools (NASDAQ:LAB) & Hinge Health (NYSE:HNGE) Critical Contrast - Defense World
What analysts say about Standard BioTools Inc stockExit Strategy Tips & Investment Portfolio Recommendations - earlytimes.in
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 80% - simplywall.st
Standard BioTools: Outlook Still Murky (NASDAQ:LAB) - Seeking Alpha
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% – Here’s Why - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1%What's Next? - MarketBeat
What Standard BioTools Inc.'s (NASDAQ:LAB) 28% Share Price Gain Is Not Telling You - 富途牛牛
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9% – What’s Next? - Defense World
Can Standard BioTools Inc. stock sustain market leadershipWeekly Profit Summary & Detailed Earnings Play Alerts - Улправда
Is Standard BioTools Inc. stock a buy before product launchesQuarterly Portfolio Report & AI Powered Trade Plan Recommendations - bolumsonucanavari.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9%Time to Sell? - MarketBeat
Is Standard BioTools Inc. stock a top pick in earnings seasonIndex Update & Reliable Intraday Trade Alerts - Bölüm Sonu Canavarı
Is Standard BioTools Inc. (FLB) stock bottoming after sell offWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
Will Standard BioTools Inc. stock outperform growth indexesBreakout Watch & Expert Verified Movement Alerts - Улправда
Is Standard BioTools Inc. stock a safe investment in uncertain markets2025 Buyback Activity & Safe Entry Zone Tips - ulpravda.ru
Will Standard BioTools Inc. stock benefit from green energy trendsGDP Growth & Trade Opportunity Analysis - Улправда
Can Standard BioTools Inc. stock maintain operating marginsTrade Signal Summary & Daily Stock Trend Watchlist - Улправда
Analysts Set Standard BioTools Inc. (NASDAQ:LAB) Price Target at $1.35 - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Zacks Research - MarketBeat
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - setenews.com
Should investors be concerned about Standard BioTools Inc (LAB)? - uspostnews.com
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 75,000 Shares - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Purchases 125,000 Shares of Stock - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Acquires 150,000 Shares of Stock - MarketBeat
Standard BioTools Inc. Stock (LAB) Opinions on Insider Purchases - Quiver Quantitative
Subdued Growth No Barrier To Standard BioTools Inc. (NASDAQ:LAB) With Shares Advancing 26% - simplywall.st
Casdin funds buy Standard Biotools (LAB) shares for $502,570 By Investing.com - Investing.com UK
Will Standard BioTools Inc. stock attract ESG investorsQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
Why Standard BioTools Inc. (FLB) stock is upgraded to buy2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Casdin funds buy Standard Biotools (LAB) shares for $502,570 - Investing.com
Casdin Capital, LLC Increases Stake in Standard BioTools Inc - GuruFocus
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - MSN
Why Standard BioTools Inc. (FLB) stock is trending on social mediaEarnings Risk Summary & Free High Return Stock Watch Alerts - Newser
How Standard BioTools Inc. (FLB) stock trades in high volatility2025 Market Sentiment & Daily Price Action Insights - Newser
Why analysts raise outlook for Standard BioTools Inc. (FLB) stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Weekly Trades: Will Standard BioTools Inc stock attract ESG investorsJuly 2025 Price Swings & AI Driven Stock Movement Reports - BỘ NỘI VỤ
Published on: 2025-12-01 23:56:21 - Newser
BioTools Inc.: A Deep Dive (NASDAQ:LAB) - Seeking Alpha
Penny Stocks To Watch In December 2025 - simplywall.st
Standard BioTools (NASDAQ:LAB) Director Acquires $214,500.00 in Stock - MarketBeat
Casdin Partners Master Fund, L Buys 7,550,000 Shares of Standard BioTools (NASDAQ:LAB) Stock - MarketBeat
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen - MSN
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
Aug Intraday: Can Standard BioTools Inc. stock maintain operating marginsWeekly Stock Summary & Weekly Watchlist for Hot Stocks - moha.gov.vn
[Form 4] STANDARD BIOTOOLS INC. Insider Trading Activity - Stock Titan
Standard BioTools (NASDAQ:LAB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Institutional Owners May Be Pleased With Recent Gains After 14% Loss Over the Past Year - 富途牛牛
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):